Altimmune shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Altimmune
Tip: Access up to 7 years of quarterly data
All positions including Altimmune held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Altimmune by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13k | 4.2k | 3.08 |
| 2025-12-31 | $2.4k | 672 | 3.61 |
| 2025-06-30 | $16k | 4.2k | 3.87 |
| 2025-03-31 | $534k | 107k | 5.00 |
| 2024-12-31 | $666k | 92k | 7.21 |
| 2024-09-30 | $487k | 79k | 6.14 |
| 2024-06-30 | $700k | 105k | 6.65 |
| 2024-03-31 | $185k | 18k | 10.18 |
| 2023-06-30 | $81k | 19k | 4.22 |
| 2023-03-31 | $81k | 19k | 4.22 |
| 2022-12-31 | $900k | 55k | 16.45 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas